Vor Biopharma Inc.

VOR

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001817229

SEC filings (opens in a new tab)

In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Vor Biopharma Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of VOR: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	55	1	80	+26
Shares	25.5M	770.3K	40.4M	+15.7M (+63.3%)
Value	$332.0M	$10.1M	$716.9M	+$394.9M (+122.7%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Vor Biopharma Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to VOR in Q1 2026
Institution	Shares	Value	% of portfolio
TCG Crossover Management, LLC	5,673,078	$96.5M	2.76%
Vanguard Capital Management LLC	1,433,280	$25.6M	0.00%
Marshall Wace, LLP	1,153,276	$20.6M	0.02%
Rosalind Advisors, Inc.	700,000	$12.5M	5.12%
Boothbay Fund Management, LLC	555,702	$9.91M	0.23%
Braidwell LP	466,774	$8.33M	0.28%
Clearline Capital LP	326,168	$5.82M	0.45%
Propel Bio Management, LLC	314,543	$5.59M	3.52%
Vanguard Fiduciary Trust Co	185,511	$3.31M	0.00%
Jump Financial, LLC	173,028	$3.09M	0.05%
Renaissance Technologies LLC	128,839	$2.30M	0.00%
Axiom Investors LLC	95,745	$1.71M	0.02%
Simplify Asset Management Inc.	53,510	$954.6K	0.01%
Rafferty Asset Management, LLC	50,505	$901.0K	0.00%
Brevan Howard Capital Management LP	42,217	$753.2K	0.01%
Irenic Capital Management LP	32,663	$582.7K	0.05%
Charles Schwab Investment Management Inc	22,216	$396.3K	0.00%
Profund Advisors LLC	22,015	$392.7K	0.01%
Scientech Research LLC	15,047	$268.4K	0.22%
Axq Capital, LP	15,019	$267.9K	0.03%
SEI Investments Co	13,716	$244.5K	0.00%
Vanguard Global Advisers, LLC	12,875	$229.7K	0.00%
Winton Group Ltd	11,870	$211.8K	0.01%
Cannon Global Investment Management, LLC	11,700	$208.7K	0.51%
Invesco Ltd.	11,600	$206.9K	0.00%
Diametric Capital, LP	10,070	$179.6K	0.05%
Group One Trading, L.P.	9,065	$161.7K	0.01%
Mirae Asset Global ETFs Holdings Ltd.	3,513	$51.6K	0.00%
Quantbot Technologies LP	307	$5.48K	0.00%
The PNC Financial Services Group, Inc.	246	$4.39K	0.00%
Parallel Advisors, LLC	48	$856	0.00%
Signaturefd, LLC	39	$696	0.00%
Ameritas Advisory Services, LLC	37	$660	0.00%
Fortitude Family Office, LLC	31	$553	0.00%
WPG Advisers, LLC	21	$375	0.00%

Sold out (9)

Institutions that held Vor Biopharma Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of VOR in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Findell Capital Management LLC	231,000	$3.02M
Ameriprise Financial Inc	163,061	$2.13M
Omers Administration Corp	20,700	$270.8K
XTX Topco Ltd	17,542	$229.4K
Persistent Asset Partners Ltd	10,798	$141.2K
Shay Capital LLC	10,745	$140.5K
Susquehanna Portfolio Strategies, LLC	10,207	$133.5K
Chung Wu Investment Group, LLC	8,300	$108.6K
Hudson Bay Capital Management LP	5,110	$66.8K

Not filed for Q1 2026 yet (1)

Institutions that held Vor Biopharma Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VOR in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	770,250	$10.1M